Riluzole for Parkinson plus disorders
نویسندگان
چکیده
منابع مشابه
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
Parkinson plus diseases, comprising mainly progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are rare neurodegenerative conditions. We designed a double-blind randomized placebo-controlled trial of riluzole as a potential disease-modifying agent in Parkinson plus disorders (NNIPPS: Neuroprotection and Natural History in Parkinson Plus Syndromes). We analysed the accuracy of...
متن کاملParkinson-Plus Syndromes
Editor(s): Christopher C Luzzio, MD , Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison; Francisco Talavera, PharmD, PhD , Senior Pharmacy Editor, eMedicine; Nestor Galvez-Jimenez, MD , Program Director of Movement Disorders, Director of Neurology Residency Training Program, Department of Neurology, Division of Medicine, Cleveland Clinic Florida; Matthew ...
متن کاملSleep disorders in Parkinson disease
Parkinson disease is a progressive degenerative disease causing motor and non-motor symptoms. Sleep disturbance is a common non-motor symptom and significantly affect the day to day activities of patients and their quality of life. Though common, sleep disturbance is an under diagnosed feature of Parkinson disease (PD). Night-time sleep disturbances have been reported in as many as 60 to 98% of...
متن کاملReduced Risk Factors for Vascular Disorders in Parkinson Disease Patients
Background and Purpose—Sympathetic hyperactivity is a contributing cause of vascular disorders because it increases blood pressure, blood sugar, and blood lipids. Pervasive compromise of the central and peripheral autonomic nervous systems is common in idiopathic Parkinson disease (IPD) resulting in reduced sympathetic and parasympathetic function. We hypothesized that IPD was associated with r...
متن کاملParkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
A gradual loss of dopamine-producing nerve cells gives rise to a common neurodegenerative Parkinson's disease (PD). This disease causes a neurotransmitter imbalance in the brain and initiates a cascade of complications in the rest of the body that appears as distressing symptoms which include gait problems, tremor, gastrointestinal (GI) disorders and cognitive decline. To aid dopamine deficienc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2017
ISSN: 1465-1858
DOI: 10.1002/14651858.cd011304.pub2